Actively Recruiting
POEM-F for Achalasia International Study
Led by Chinese University of Hong Kong · Updated on 2024-12-03
81
Participants Needed
7
Research Sites
152 weeks
Total Duration
On this page
Sponsors
C
Chinese University of Hong Kong
Lead Sponsor
D
Deenanath Mangeshkar Hospital and Research Centre
Collaborating Sponsor
AI-Summary
What this Trial Is About
Per-oral endoscopic myotomy (POEM) has emerged as the endoscopic treatment of choice for achalasia, offering comparable symptom relief with laparoscopic Heller's cardiomyotomy. The main concern with POEM is the higher incidence of post-procedure gastroesophageal reflux disease (GERD), occurring in up to 50-60% of patients. In order to reduce the risk of GERD, endoscopic fundoplication has been developed as a novel procedure mimicking surgical anterior partial fundoplication that can be performed in the same session as POEM (POEM-F). Case series of POEM-F in patients with achalasia reported encouraging outcomes of low GERD rate of \~12% at 1 year. Prospective comparative data between POEM-F and conventional POEM on post-procedure GERD is current lacking. The investigators therefore designed an international multicenter prospective randomized study to investigate the efficacy of POEM-F. The investigators postulate that POEM-F could reduce the incidence of post-procedure GERD when compared with conventional POEM. This is an international multicenter randomized controlled trial conducted between high volume expert centers from Hong Kong SAR, China, India and United States of America. Adult patients with manometry confirmed achalasia would be randomised to undergo POEM-F or POEM. The procedure would be performed by experts with vast experience in POEM. The primary outcome is the incidence of post-procedure GERD at 1 year, defined by the updated Lyon consensus. Secondary outcomes include technical and clinical success rates, adverse events, post-POEM endoscopic and manometry findings as well as patients' symptom scores. Sample size calculation Based on existing pilot comparative data on POEM-F and POEM, it is estimated that 84 patients would be required to demonstrate a difference in post-procedure GERD of 47.6% to 18.2%, with 80% power and false positive rate of 0.05, accounting for 10% loss to follow-up. Purpose and potential The current study proposal could demonstrate the superiority of POEM-F over POEM in reducing post-procedural GERD. It would also demonstrate the safety and reproducibility of the technique in expert centers across the globe. It could potentially replace conventional POEM as the preferred minimally invasive endoscopic treatment for achalasia.
CONDITIONS
Official Title
POEM-F for Achalasia International Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged 18 to 65 years with symptomatic achalasia type I or II
- Able to understand and comply with study tasks, including filling out symptom questionnaires and providing informed consent
- Patients with achalasia type I, II, or III who are either treatment-na�efve or have failed prior balloon or pneumatic dilation treatment
You will not qualify if you...
- Unable or unwilling to provide consent
- Previous esophageal or gastric surgery
- Prior achalasia treatments including Heller myotomy or POEM
- Sigmoid achalasia or significant esophageal dilation greater than 6 cm in the lower esophagus
- Damaged mucosal lining in the lower esophagus such as ulcers or fibrotic scars
- Large hiatal hernias with axial length over 2 cm and Hill grade above 2
- Significant heart or lung diseases limiting general anesthesia, including ASA grade III or higher
- Obesity with body mass index of 30 or higher
- Pregnant, planning pregnancy, or breastfeeding women
- Uncorrectable blood clotting problems with INR above 1.5 or platelet count below 50,000 per microliter
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287
Not Yet Recruiting
2
Nanfang Hospital, Southern Medical University
Guangzhou, China
Not Yet Recruiting
3
The Chinese University of Hong Kong
Hong Kong, Hong Kong
Actively Recruiting
4
Post Graduate Institute of Medical Education and Research
Chandigarh, India
Not Yet Recruiting
5
Asian Institute of Gastroenterology
Hyderabad, India
Not Yet Recruiting
6
Baldota Institute of Digestive Sciences
Mumbai, India
Not Yet Recruiting
7
Deenanath Mangeshkar Hospital & Research Center
Pune, India
Not Yet Recruiting
Research Team
H
Hon Chi Yip, FRCSEd
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here